Down's syndrome screening

Comment

J E Haddow et al. Lancet. 1996.

. 1996 Jun 8;347(9015):1625; author reply 1625-6.

No abstract available

Comment on

Down's syndrome screening in the UK.
Nicolaides KH, Sebire NJ, Snijders RJ, Johnson S. Nicolaides KH, et al. Lancet. 1996 Mar 30;347(9005):906-7. doi: 10.1016/s0140-6736(96)91391-4. Lancet. 1996. PMID: 8622427 No abstract available.

Down's syndrome screening.
Gill M. Gill M. Lancet. 1996 Jun 8;347(9015):1625. Lancet. 1996. PMID: 8667892 No abstract available.
Down's syndrome screening in the UK.
Nicolaides KH, Sebire NJ, Snijders RJ, Johnson S. Nicolaides KH, et al. Lancet. 1996 Mar 30;347(9005):906-7. doi: 10.1016/s0140-6736(96)91391-4. Lancet. 1996. PMID: 8622427 No abstract available.
Implementation of an antenatal serum screening programme for Down's syndrome in two districts (Brighton and Eastbourne). The Brighton and Eastbourne Down's Syndrome Screening Group.
Piggott M, Wilkinson P, Bennett J. Piggott M, et al. J Med Screen. 1994 Jan;1(1):45-9. doi: 10.1177/096914139400100109. J Med Screen. 1994. PMID: 8790485
Prenatal biochemical screening for Down's syndrome and neural tube defects.
Wald NJ, Kennard A. Wald NJ, et al. Curr Opin Obstet Gynecol. 1992 Apr;4(2):302-7. Curr Opin Obstet Gynecol. 1992. PMID: 1373963 Review.
[An analysis of the causes for the occurrence of Down's syndrome and the current approaches to its prevention at the stage of mass prenatal ultrasonic and immunobiochemical screening of pregnant women].
Veropotvelian NP, Veropotvelian PN, Korotkov AV. Veropotvelian NP, et al. Tsitol Genet. 1995 Sep-Oct;29(5):82-92. Tsitol Genet. 1995. PMID: 8721852 Review. Russian.